Oxford BioTherapeutics Appoints Bryan Morton as Chairman

by | 26th Jun 2013 | Appointments

Bryan Morton has over 30 years’ experience as a successful entrepreneur and senior manager in the pharmaceutical industry. Morton was previously CEO of EUSA Pharma, a global speciality oncology company, which was acquired by Jazz Pharmaceuticals in 2012 for $700 million.

Bryan Morton has over 30 years’ experience as a successful entrepreneur and senior manager in the pharmaceutical industry. Morton was previously CEO of EUSA Pharma, a global speciality oncology company, which was acquired by Jazz Pharmaceuticals in 2012 for $700 million.

Tags


Related posts